news
Limited supply of antimalarial drugs may prevent use against COVID-19, say doctors
An open letter from doctors highlights that although chloroquine and hydroxychloroquine are strong candidates to fight COVID-19, there is a limited supply.
List view / Grid view
European League Against Rheumatism (EULAR)
news
Study finds biosimilar switching not suitable for all patients
10 June 2016 | By Victoria White, Digital Content Producer
A study presented at EULAR showed that when antibodies develop in response to the infliximab, they also cross-react with the biosimilar of infliximab...
news
Bimekizumab demonstrates positive results in patients with psoriatic arthritis
10 June 2016 | By Victoria White, Digital Content Producer
In a Phase Ib study, bimekizumab showed fast and sustained efficacy on disease activity measures in both skin and joints and was well-tolerated...
news
New data for baricitinib in rheumatoid arthritis presented at EULAR
Lilly and Incyte have announced new data for baricitinib in rheumatoid arthritis (RA) at the Annual European Congress of Rheumatology (EULAR 2016).
news
Efficacy and safety of Biogen’s anti-TNF biosimilars presented at EULAR
9 June 2016 | By Victoria White, Digital Content Producer
Data demonstrating long-term comparable efficacy, safety and immunogenicity of Benepali (etanercept) and Flixabi (infliximab) have been presented at EULAR...
news
Greater response with GSK’s Benlysta vs placebo in SLE study
8 June 2016 | By Victoria White, Digital Content Producer
Patients with SLE experienced a significantly greater response to treatment with Benlysta administered via subcutaneous injection compared to placebo...
news
Sirukumab meets both co-primary endpoints in rheumatoid arthritis study
8 June 2016 | By Victoria White, Digital Content Producer
The SIRROUND-D study met both co-primary endpoints in evaluating treatment with sirukumab in adult patients with active rheumatoid arthritis...
news
Novartis plans head-to-head studies of Cosentyx versus Humira
8 June 2016 | By Victoria White, Digital Content Producer
Long-term analyses suggest Cosentyx may lead to higher responses than Humira in improving signs and symptoms of ankylosing spondylitis and psoriatic arthritis...
news
AstraZeneca announces Phase III results for lesinurad in combination with febuxostat in patients with tophaceous gout
15 June 2015 | By Victoria White
AstraZeneca presented results from its Phase III trial investigating lesinurad in combination with febuxostat in patients with tophaceous gout at EULAR 2015...
news
Positive results from Phase 3 study evaluating Cimzia in DMARD-naïve rheumatoid arthritis patients
15 June 2015 | By Victoria White
UCB has announced data from a Phase 3 study that showed the substantial benefits, at 52 weeks, of adding Cimzia to optimised methotrexate treatment...
news
Chickenpox vaccine can be effective and safe even in children with paediatric rheumatic disease
12 June 2015 | By Victoria White
Results from a new study show that the chickenpox vaccine can be safe even in children with rheumatic disease receiving immunosuppression treatment...
news
Janssen to present 17 abstracts in ankylosing spondylitis, rheumatoid arthritis, psoriatic arthritis and psoriasis at EULAR
11 June 2015 | By Victoria White
Seventeen Janssen Immunology abstracts in ankylosing spondylitis, rheumatoid arthritis, psoriatic arthritis and psoriasis, will be presented at EULAR...
news
Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit ovulation after just 10 days
11 June 2015 | By Victoria White
The results of a study presented at EULAR 2015 show that NSAIDs, such as diclofenac, significantly inhibit ovulation in women with mild musculoskeletal pain...
news
New data on quality-of-life benefits of Simponi in treating patients with nr-axial SpA presented at EULAR 2015
10 June 2015 | By Victoria White
MSD has announced additional data from a subanalysis of the GO-AHEAD study on the effect of Simponi in treating patients with nr-axial SpA...
